Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving BevacizumabS. Kommoss,F. Heitz,B. J. N. Winterhoff,A. Du Bois,C. Wang,J. Sehouli,C. Aliferis, R. Kimmoig,J. Wang,S. Ma,N. De Gregorio,S. Mahner,R. Tourani,T. W. Park-Simon,K. Baumann,F. A. Taran,F. Kommoss,W. Schroeder,S. Dowdy,J. PfistererJOURNAL OF CLINICAL ONCOLOGY(2018)引用 3|浏览93暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要